GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,366.00p
   
  • Change Today:
    -27.60p
  • 52 Week High: 1,846.00
  • 52 Week Low: 1,291.80
  • Currency: UK Pounds
  • Shares Issued: 5,017m
  • Volume: 6,658,513
  • Market Cap: 68,538m
  • RiskGrade: 133

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.9% 5.7%
Div Cover 1.5 1.5
Op Mrgn 20.6% 24.1%
ROCE 59.5%  
Latest F'cast
P/E 11.0 12.0
PEG 2.9 n/a
Pr/Revenue 2.0 2.0
Pr/Book 3.7  
Latest F'cast
Revenue 9.5% 1.5%
PBT 29.6% 32.4%
EPS 3.8% -6.1%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 34,251.19 8,237.83 116.39p 11.7 n/a -6% 80.00p 5.7%
31-Dec-21 35,510.19 8,504.63 115.92p 11.8 n/a -0% 80.00p 5.7%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Block listing Interim Review 23-Nov-2020 08:59 RNS
Holding(s) in Company 19-Nov-2020 17:40 RNS
Director/PDMR Shareholding 17-Nov-2020 17:48 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
12-Nov-20 Buy Dividends Hal Barron 1,438.64p 86 1,237.23
12-Nov-20 Buy Dividends Hal Barron 1,438.64p 3,871 55,689.88
10-Nov-20 Transfer From Emma Walmsley 0.000p 9 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,366.00p
Change Today -27.60p
% Change -1.98 %
52 Week High 1,846.00
52 Week Low 1,291.80
Volume 6,658,513
Shares Issued 5,017m
Market Cap 68,538m
RiskGrade 133

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.11% above the market average10.11% above the market average10.11% above the market average10.11% above the market average10.11% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
56.97% below the market average56.97% below the market average56.97% below the market average56.97% below the market average56.97% below the market average
89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average
Income
93.13% above the market average93.13% above the market average93.13% above the market average93.13% above the market average93.13% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
50.19% above the market average50.19% above the market average50.19% above the market average50.19% above the market average50.19% above the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

What The Brokers Say

Strong Buy 12
Buy 1
Neutral 11
Sell 0
Strong Sell 1
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q3 Q2
Ex-Div 12-Nov-20 13-Aug-20
Paid 14-Jan-21 08-Oct-20
Amount 19.00p 19.00p

Trades for 23-Nov-2020

Time Volume / Share Price
16:43 7,400 @ 1,370.00p
16:35 2,397,031 @ 1,366.00p
16:29 1 @ 1,371.40p
16:29 108 @ 1,371.40p
16:29 948 @ 1,371.40p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page